SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-138505
Filing Date
2021-11-15
Accepted
2021-11-15 07:00:46
Documents
49
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bcli-20211030x10q.htm   iXBRL 10-Q 1111595
2 EXHIBIT 10.1 bcli-20211030xex10d1.htm EX-10.1 5601
3 EXHIBIT 31.1 bcli-20211030xex31d1.htm EX-31.1 9425
4 EXHIBIT 31.2 bcli-20211030xex31d2.htm EX-31.2 9314
5 EXHIBIT 32.1 bcli-20211030xex32d1.htm EX-32.1 7169
6 EXHIBIT 32.2 bcli-20211030xex32d2.htm EX-32.2 6227
  Complete submission text file 0001104659-21-138505.txt   3549830

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA bcli-20211030.xsd EX-101.SCH 27382
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcli-20211030_cal.xml EX-101.CAL 28961
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcli-20211030_def.xml EX-101.DEF 82866
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20211030_lab.xml EX-101.LAB 198309
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20211030_pre.xml EX-101.PRE 160473
12 EXTRACTED XBRL INSTANCE DOCUMENT bcli-20211030x10q_htm.xml XML 445205
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36641 | Film No.: 211406236
SIC: 2836 Biological Products, (No Diagnostic Substances)